期刊文献+

晚期非小细胞肺癌的整体治疗

Holistic therapy of advanced non-small cell lung
原文传递
导出
摘要 肿瘤的整体治疗是根据患者的个体特征(如全身状况、组织学类型和分子分型)结合肿瘤临床研究的最新成果为肿瘤患者提供最佳的整体治疗方案.肿瘤整体治疗体现了个体、精准、全程和实时的治疗理念,包括序贯、同步、间歇和节拍的治疗模式.肿瘤整体治疗将为肿瘤医生和患者提供简单、最佳的治疗选择. Holistic therapy of cancer is helping to design more effective cancer therapies by combination individual properties (such as performance status,histological types and molecular types) and novel clinical results.Holistic therapy in oncology reflects individual,precision,whole course and real-time treatment strategy,and includes sequential,synchronizational,interval and metronomic therapy models.Holistic therapy in oncology would be help in selecting appropriate choices for patients and clinic doctors.
出处 《国际肿瘤学杂志》 CAS 2017年第8期612-614,共3页 Journal of International Oncology
基金 甘肃省自然科学基金(1308RJZA181)
关键词 非小细胞肺 肿瘤 整体治疗 Carcinoma,non-small-cell lung Neoplasms Holistic therapy
  • 相关文献

参考文献1

二级参考文献16

  • 1MAITLAND M L, SCHILSKY R L. Clinical trials in the era of personalized oncology[J]. CA Cancer J Clin, 2011, 61 (6):365-3+81. 被引量:1
  • 2ALLEGRA C, SARGENT D J. Adjuvant therapy for colon cancer-the pace quickens[J]. N Engl J Med, 2005, 352(26):2746-2748. 被引量:1
  • 3ANDRE N, PASQUIER E. For cancer, seek and destroy or live and let live?[J] Nature, 2009, 460(7253):324. 被引量:1
  • 4GATENBY R A. A change of strategy in the war on cancer[J]. Nature, 2009, 459(7246):508-5090. 被引量:1
  • 5HAYDEN E C. Personalized cancer therapy gets closer[J]. Nature, 2009, 458(7235): 131-132. 被引量:1
  • 6BOKEMEYER C, BONDARENKO I, HARTMANN J T, et al. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS studv[J]. Ann Oneal, 2011,22(7):1535-1546. 被引量:1
  • 7LAZAR A A, COLE B F, BONETTI M, et al. Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot[J]. J Clin Oncol, 2010, 28(29):4539-4544. 被引量:1
  • 8SAGLIO G, KIM D W, ISSARAGRISIL 5, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukernia[J]. N Engl J Med, 2010,362(24):2251-2259. 被引量:1
  • 9CHEN Z, CHENG K, WALTON Z, et al. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response[J]. Nature, 2012, 483(7391):613-617. 被引量:1
  • 10GONZALEZ-ANGULO A M, HENNESSY B T, MILLS G B. Future of personalized medicine in oncology: a systems biology approach[J].J Clin Oncol, 2010, 28(16):2777-2783. 被引量:1

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部